You’re sitting in a conference room, reviewing your product launch plan, when your competitor announces positive … Competitive Intelligence Surge: Elevating Pharma Marketing InsightsRead more
Industry Landscape
Articles under this category focus on macro trends, big pharma behavior, and annual outlooks.
FDA’s Crackdown on Pharma’s Digital Marketing: What the Warning Letters to Lilly, Novo, and Novartis Signal for the Future of DTC Advertising
For years, pharmaceutical marketing teams have operated in a gray zone—especially on social media. Branded content, … FDA’s Crackdown on Pharma’s Digital Marketing: What the Warning Letters to Lilly, Novo, and Novartis Signal for the Future of DTC AdvertisingRead more
AI-Powered Territory Management for Pharma Sales Success in 2025
The pharmaceutical sales landscape is evolving faster than ever. Field access is shrinking, prescribing behavior is … AI-Powered Territory Management for Pharma Sales Success in 2025Read more
Optimizing ROI Measurement: Overcoming Market Access Challenges in Pharma Sales
You look at the latest sales report and notice a familiar issue: your market access team … Optimizing ROI Measurement: Overcoming Market Access Challenges in Pharma SalesRead more
Personalized Marketing in Pharma: Key Tactics for 2025 Success
The pharmaceutical industry is at a crossroads. For decades, marketing relied on broad campaigns and mass … Personalized Marketing in Pharma: Key Tactics for 2025 SuccessRead more
AI in Pharma Marketing: How AI in Pharma Marketing Is Revolutionizing HCP Engagement in 2025
A decade ago, pharmaceutical marketers believed digital transformation meant launching an app or building a CRM … AI in Pharma Marketing: How AI in Pharma Marketing Is Revolutionizing HCP Engagement in 2025Read more
GLP-1 and the Obesity Market: The Sales Playbook Behind Pharma’s New Gold Rush
The world’s largest pharmaceutical companies have found their new gold rush, and it’s not oncology this … GLP-1 and the Obesity Market: The Sales Playbook Behind Pharma’s New Gold RushRead more
M&A Activity Boosting Biotech Sales Pipelines: How High-Stakes Deals Are Reshaping Pharma Innovation
When Genmab announced its $8 billion acquisition of Merus, industry analysts didn’t just see another consolidation … M&A Activity Boosting Biotech Sales Pipelines: How High-Stakes Deals Are Reshaping Pharma InnovationRead more
Direct-to-Consumer Advertising Oversight: How FDA’s Crackdown Is Redefining Pharma Marketing
The glossy world of pharmaceutical advertising is facing its biggest regulatory reset in two decades. For … Direct-to-Consumer Advertising Oversight: How FDA’s Crackdown Is Redefining Pharma MarketingRead more
Oncology Drug Sales Boom: How mAbs, ADCs, and ICIs Are Reshaping Commercial Strategy
The oncology commercial landscape is entering a high-velocity phase. You may have seen dramatic headlines: double-digit … Oncology Drug Sales Boom: How mAbs, ADCs, and ICIs Are Reshaping Commercial StrategyRead more